News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
582 Results
Type
Article (60)
Press Release (522)
Section
Business (221)
Deals (30)
Drug Development (94)
FDA (3)
Job Trends (6)
News (297)
Policy (16)
Tag
Academia (2)
Alliances (41)
Alzheimer's disease (1)
Approvals (4)
Best Places to Work (4)
Cancer (5)
CDMO (1)
Clinical research (94)
Collaboration (1)
COVID-19 (10)
C-suite (4)
Data (24)
Depression (1)
Diagnostics (2)
Earnings (15)
Events (94)
Executive appointments (2)
FDA (7)
Funding (8)
Gene editing (1)
GLP-1 (3)
Government (2)
Healthcare (34)
Hematology (1)
Infectious disease (10)
Inflammatory bowel disease (1)
IPO (21)
Job creations (2)
Layoffs (1)
Legal (3)
Lung cancer (1)
Medical device (2)
Medtech (2)
Mergers & acquisitions (10)
Neuropsychiatric disorders (1)
Neuroscience (4)
NextGen: Class of 2026 (14)
Non-profit (2)
Pancreatic cancer (1)
Patient recruitment (3)
People (119)
Phase 1 (44)
Phase 2 (52)
Phase 3 (15)
Pipeline (16)
Preclinical (17)
Rare diseases (1)
Real estate (3)
Regulatory (15)
Research institute (4)
Schizophrenia (2)
Series A (2)
Series B (4)
Startups (17)
Venture capital (2)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (33)
2026 (25)
2025 (37)
2024 (40)
2023 (31)
2022 (59)
2021 (73)
2020 (43)
2019 (68)
2018 (44)
2017 (37)
2016 (34)
2015 (33)
2014 (9)
2013 (8)
2012 (5)
2011 (7)
2010 (5)
Location
Asia (9)
California (1)
Delaware (1)
Europe (16)
Massachusetts (70)
Minnesota (1)
New York (2)
Northern California (1)
Pennsylvania (1)
United States (75)
Virginia (1)
582 Results for "puretech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PureTech Founded Entity Celea Therapeutics to Deliver Two Presentations at the Upcoming European Respiratory Society (ERS) Congress
August 25, 2026
·
8 min read
Press Releases
PureTech Health: Notice of Results
April 13, 2026
·
2 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers
September 9, 2026
·
12 min read
Press Releases
PureTech Announces Successful End-of-Phase 1 Meeting with U.S. Food and Drug Administration (FDA) and Receipt of Fast Track Designation for LYT-200 in Relapsed/Refractory (R/R) High-Risk Myelodysplastic Syndromes (HR-MDS)
September 21, 2026
·
8 min read
Press Releases
PureTech Announces Annual Results for Year Ended December 31, 2025
April 29, 2026
·
19 min read
Press Releases
PureTech to Showcase Deupirfenidone Program at the American Thoracic Society International Conference
May 13, 2026
·
7 min read
Press Releases
PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
July 13, 2026
·
11 min read
Press Releases
PureTech Founded Entity Celea Therapeutics Completes $180 Million Financing to Advance Deupirfenidone as a Potential New Standard of Care to Treat Idiopathic Pulmonary Fibrosis (IPF)
July 2, 2026
·
12 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 9, 2026
·
12 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
April 27, 2026
·
6 min read
1 of 59
Next
